全体要約
新型コロナウイルス肺炎におけるAI市場は、2022年の売上を基に、2023年から2029年にかけての予測を地域別および市場セクター別に分析しています。市場規模は、2022年から2029年にかけて成長が見込まれ、特にアメリカ、中国、ヨーロッパの市場が注目されています。主要企業にはInfervision、BlueDot、Yitu Healthcare、SPHCCが含まれ、2022年には上位2社が市場の大部分を占めています。
このレポートは、新型コロナウイルス肺炎におけるAIの製品セグメンテーション、企業形成、収益、マーケットシェア、最新の開発動向、M&A活動を強調しています。また、地域別、アプリケーション別、タイプ別に市場のトレンドや成長機会を評価し、今後の市場の動向を明らかにしています。特に、病院や感染症センターでの利用が増加する見込みです。
関連する質問
Infervision, BlueDot, Yitu Healthcare, SPHCC
製品セグメンテーションの重要なトレンド, 地域別市場の成長機会, 主要企業の戦略分析
概要
このインサイトレポートは、COVID-19におけるAIのグローバルな状況を包括的に分析し、製品セグメンテーション、企業の形成、収益、市場シェア、最新の開発、M&A活動に関連する主要なトレンドを強調しています。また、このレポートは、COVID-19におけるAIポートフォリオや能力、市場参入戦略、市場ポジション、地理的足跡に焦点を当て、急速に成長するCOVID-19におけるAI市場におけるこれら企業の独自の位置をよりよく理解するために、主要なグローバル企業の戦略を分析しています。
このインサイトレポートは、AIによる新型コロナウイルス肺炎の世界的な展望を形成する主要な市場トレンド、ドライバー、および影響要因を評価し、タイプ別、アプリケーション別、地域別、市場規模別に予測を分解して、新たな機会のポケットを浮き彫りにします。数百のボトムアップの定性的および定量的な市場インプットに基づいた透明な手法を用いたこの研究予測は、AIによる新型コロナウイルス肺炎の現在の状態と将来の軌道に関する非常に細分化された視点を提供します。
新型コロナウイルス肺炎におけるAIの市場規模は、2022年のXX米ドルから2029年のXX米ドルまで成長する見込みです。また、2023年から2029年までの間にXX%のCAGRで成長することが期待されています。
アメリカ合衆国における新型コロナウイルス肺炎におけるAI市場は、2022年のXX米ドルから2029年までにXX米ドルに増加する見込みで、2023年から2029年までの間にXX%の年間成長率（CAGR）を示します。
中国における新型コロナウイルス肺炎におけるAI市場は、2022年のXX米ドルから2029年にはXX米ドルに増加すると推定されており、2023年から2029年までのCAGRはXX%です。
新型コロナウイルス肺炎におけるAIの欧州市場は、2022年のXX米ドルから2029年までにXX米ドルに増加すると推定されており、2023年から2029年の間にXX%のCAGRで成長する見込みです。
新型コロナウイルス肺炎におけるAIの主要企業には、Infervision、BlueDot、Yitu Healthcare、SPHCCなどが含まれます。収益の観点から、2022年において、世界の二大企業はほぼXX%のシェアを占めました。
この報告書は、商品タイプ、アプリケーション、主要なプレイヤー、主要な地域および国別の新型コロナウイルス肺炎におけるAIの包括的な概要、市場シェア、成長機会を提示します。
市場セグメンテーション：
種類別セグメンテーション
発生前の予測
CT診断
その他
用途別のセグメンテーション
病院
感染症センター
その他
この報告書では、市場を地域別に分割しています。
アメリカ大陸
アメリカ合衆国
カナダ
メキシコ
ブラジル
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東およびアフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
プロファイルされた以下の企業は、主要な専門家からの情報収集と企業のカバレッジ、製品ポートフォリオ、市場浸透の分析に基づいて選定されています。
インフェルビジョン
ブルードット
イートゥヘルスケア
SPHCC
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 調査範囲
1.1 市場イントロダクション
1.2 対象年
1.3 調査目的
1.4 市場調査手法
1.5 調査プロセスとデータソース
1.6 経済指標
1.7 通貨
1.8 市場予測における留意事項
2 エグゼクティブサマリー
2.1 世界市場概要
2.1.1 グローバルの新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI市場規模、（2018年～2029年）
2.1.2 新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI市場規模、CAGR（地域別）（2018年 vs 2022年 vs 2029年）
2.2 新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAIセグメント、タイプ別
2.2.1 アウトブレーク前予想
2.2.2 CT診断
2.2.3 その他
2.3 新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI市場規模：タイプ別
2.3.1 新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI市場規模、CAGR（タイプ別）（2018年 vs 2022年 vs 2029年）
2.3.2 グローバルの新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI市場規模、市場シェア（タイプ別）（2018年～2023年）
2.4 新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAIセグメント、用途別
2.4.1 病院
2.4.2 感染症センター
2.4.3 その他
2.5 新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI市場規模：用途別
2.5.1 新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI市場規模、CAGR（用途別）（2018年 vs 2022年 vs 2029年）
2.5.2 グローバルの新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI市場規模、市場シェア（用途別）（2018年～2023年）
3 新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI市場規模：プレイヤー別
3.1 新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI市場規模、市場シェア（プレイヤー別）
3.1.1 グローバルにおける新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI市場の収益規模、プレイヤー別（2018年～2023年）
3.1.2 グローバルにおける新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI市場の収益シェア、プレイヤー別（2018年～2023年）
3.2 グローバルの新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI市場キープレイヤー拠点および提供製品
3.3 市場集中度分析
3.3.1 競合情勢分析
3.3.2 集中度レシオ（CR3、CR5、CR10）（2021年～2023年）
3.4 新製品・潜在的参入
3.5 M&A、拡大
4 新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI、地域別
4.1 新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI市場規模（地域別）（2018年～2023年）
4.2 アメリカズにおける新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI市場規模成長（2018年〜2023年）
4.3 APACにおける新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI市場規模成長（2018年〜2023年）
4.4 ヨーロッパにおける新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI市場規模成長（2018年〜2023年）
4.5 中東・アフリカにおける新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI市場規模成長（2018年〜2023年）
5 アメリカズ
5.1 アメリカズにおける新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI市場規模、国別（2018年〜2023年）
5.2 アメリカズにおける新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI市場規模、タイプ別（2018年〜2023年）
5.3 アメリカズにおける新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI市場規模、用途別（2018年〜2023年）
5.4 米国
5.5 カナダ
5.6 メキシコ
5.7 ブラジル
6 APAC
6.1 APACにおける新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI市場規模、地域別（2018年〜2023年）
6.2 APACにおける新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI市場規模、タイプ別（2018年〜2023年）
6.3 APACにおける新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI市場規模、用途別（2018年〜2023年）
6.4 中国
6.5 日本
6.6 韓国
6.7 東南アジア
6.8 インド
6.9 オーストラリア
7 ヨーロッパ
7.1 ヨーロッパの新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI 国別（2018年～2023年）
7.2 ヨーロッパにおける新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI市場規模、タイプ別（2018年〜2023年）
7.3 ヨーロッパにおける新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI市場規模、用途別（2018年〜2023年）
7.4 ドイツ
7.5 フランス
7.6 英国
7.7 イタリア
7.8 ロシア
8 中東・アフリカ
8.1 中東・アフリカの新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI 地域別（2018年～2023年）
8.2 中東・アフリカにおける新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI市場規模、タイプ別（2018年〜2023年）
8.3 中東・アフリカにおける新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI市場規模、用途別（2018年〜2023年）
8.4 エジプト
8.5 南アフリカ
8.6 イスラエル
8.7 トルコ
8.8 GCC地域
9 市場ドライバー・課題・トレンド
9.1 市場ドライバー・成長機会
9.2 市場課題・リスク
9.3 業界トレンド
10 グローバルの新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI市場、市場予測
10.1 グローバルの新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI、市場予測（地域別）（2024年～2029年）
10.1.1 グローバルの新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI、市場予測（地域別）（2024年～2029年）
10.1.2 アメリカズの新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI、市場予測
10.1.3 APACの新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI、市場予測
10.1.4 ヨーロッパの新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI、市場予測
10.1.5 中東・アフリカの新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI、市場予測
10.2 アメリカズの新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI、市場予測（国別）（2024年～2029年）
10.3 APACの新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI、市場予測（地域別）（2024年～2029年）
10.4 ヨーロッパの新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI、市場予測（国別）（2024年～2029年）
10.5 中東・アフリカの新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI、市場予測（地域別）（2024年～2029年）
10.6 グローバルの新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI、市場予測（タイプ別）（2024年～2029年）
10.7 グローバルの新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI、市場予測（用途別）（2024年～2029年）
11 キープレイヤー分析
11.1 Infervision
11.1.1 Infervision：企業情報
11.1.2 Infervision：新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI分野の提供製品
11.1.3 Infervision：新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI収益・グロスマージンおよび市場シェア（2018年～2023年）
11.1.4 Infervision：主要事業概要
11.1.5 Infervision：直近の展開
11.2 BlueDot
11.2.1 BlueDot：企業情報
11.2.2 BlueDot：新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI分野の提供製品
11.2.3 BlueDot：新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI収益・グロスマージンおよび市場シェア（2018年～2023年）
11.2.4 BlueDot：主要事業概要
11.2.5 BlueDot：直近の展開
11.3 Yitu Healthcare
11.3.1 Yitu Healthcare：企業情報
11.3.2 Yitu Healthcare：新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI分野の提供製品
11.3.3 Yitu Healthcare：新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI収益・グロスマージンおよび市場シェア（2018年～2023年）
11.3.4 Yitu Healthcare：主要事業概要
11.3.5 Yitu Healthcare：直近の展開
11.4 SPHCC
11.4.1 SPHCC：企業情報
11.4.2 SPHCC：新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI分野の提供製品
11.4.3 SPHCC：新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI新型コロナウイルス肺炎におけるAI収益・グロスマージンおよび市場シェア（2018年～2023年）
11.4.4 SPHCC：主要事業概要
11.4.5 SPHCC：直近の展開
12 調査の結果・結論
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
This Insight Report provides a comprehensive analysis of the global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia.
The global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia players cover Infervision, BlueDot, Yitu Healthcare and SPHCC, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Pre-Outbreak Forecast
CT Diagnosis
Other
Segmentation by application
Hospital
Center for Infectious Diseases
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Infervision
BlueDot
Yitu Healthcare
SPHCC
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size 2018-2029
2.1.2 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Segment by Type
2.2.1 Pre-Outbreak Forecast
2.2.2 CT Diagnosis
2.2.3 Other
2.3 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type
2.3.1 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Type (2018-2023)
2.4 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Segment by Application
2.4.1 Hospital
2.4.2 Center for Infectious Diseases
2.4.3 Other
2.5 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application
2.5.1 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Application (2018-2023)
3 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Player
3.1 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Players
3.1.1 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue by Players (2018-2023)
3.1.2 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue Market Share by Players (2018-2023)
3.2 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia by Regions
4.1 AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Regions (2018-2023)
4.2 Americas AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth (2018-2023)
4.3 APAC AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth (2018-2023)
4.4 Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth (2018-2023)
4.5 Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth (2018-2023)
5 Americas
5.1 Americas AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2018-2023)
5.2 Americas AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2018-2023)
5.3 Americas AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Region (2018-2023)
6.2 APAC AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2018-2023)
6.3 APAC AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia by Country (2018-2023)
7.2 Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2018-2023)
7.3 Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia by Region (2018-2023)
8.2 Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2018-2023)
8.3 Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.1 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecast by Regions (2024-2029)
10.1.1 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecast by Regions (2024-2029)
10.1.2 Americas AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecast
10.1.3 APAC AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecast
10.1.4 Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecast
10.1.5 Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecast
10.2 Americas AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecast by Country (2024-2029)
10.2.1 United States AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.2.2 Canada AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.2.3 Mexico AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.2.4 Brazil AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.3 APAC AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecast by Region (2024-2029)
10.3.1 China AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.3.2 Japan AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.3.3 Korea AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.3.4 Southeast Asia AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.3.5 India AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.3.6 Australia AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.4 Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecast by Country (2024-2029)
10.4.1 Germany AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.4.2 France AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.4.3 UK AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.4.4 Italy AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.4.5 Russia AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.5 Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecast by Region (2024-2029)
10.5.1 Egypt AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.5.2 South Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.5.3 Israel AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.5.4 Turkey AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.5.5 GCC Countries AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Forecast
10.6 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecast by Type (2024-2029)
10.7 Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Infervision
11.1.1 Infervision Company Information
11.1.2 Infervision AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Product Offered
11.1.3 Infervision AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Infervision Main Business Overview
11.1.5 Infervision Latest Developments
11.2 BlueDot
11.2.1 BlueDot Company Information
11.2.2 BlueDot AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Product Offered
11.2.3 BlueDot AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 BlueDot Main Business Overview
11.2.5 BlueDot Latest Developments
11.3 Yitu Healthcare
11.3.1 Yitu Healthcare Company Information
11.3.2 Yitu Healthcare AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Product Offered
11.3.3 Yitu Healthcare AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Yitu Healthcare Main Business Overview
11.3.5 Yitu Healthcare Latest Developments
11.4 SPHCC
11.4.1 SPHCC Company Information
11.4.2 SPHCC AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Product Offered
11.4.3 SPHCC AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 SPHCC Main Business Overview
11.4.5 SPHCC Latest Developments
12 Research Findings and Conclusion
List of Tables Table 1. AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions) Table 2. Major Players of Pre-Outbreak Forecast Table 3. Major Players of CT Diagnosis Table 4. Major Players of Other Table 5. AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions) Table 6. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2018-2023) & ($ Millions) Table 7. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Type (2018-2023) Table 8. AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions) Table 9. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2018-2023) & ($ Millions) Table 10. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Application (2018-2023) Table 11. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue by Players (2018-2023) & ($ Millions) Table 12. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue Market Share by Player (2018-2023) Table 13. AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Key Players Head office and Products Offered Table 14. AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) Table 15. New Products and Potential Entrants Table 16. Mergers & Acquisitions, Expansion Table 17. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Regions 2018-2023 & ($ Millions) Table 18. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Regions (2018-2023) Table 19. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue by Country/Region (2018-2023) & ($ millions) Table 20. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue Market Share by Country/Region (2018-2023) Table 21. Americas AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2018-2023) & ($ Millions) Table 22. Americas AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Country (2018-2023) Table 23. Americas AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2018-2023) & ($ Millions) Table 24. Americas AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Type (2018-2023) Table 25. Americas AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2018-2023) & ($ Millions) Table 26. Americas AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Application (2018-2023) Table 27. APAC AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Region (2018-2023) & ($ Millions) Table 28. APAC AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Region (2018-2023) Table 29. APAC AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2018-2023) & ($ Millions) Table 30. APAC AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Type (2018-2023) Table 31. APAC AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2018-2023) & ($ Millions) Table 32. APAC AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Application (2018-2023) Table 33. Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Country (2018-2023) & ($ Millions) Table 34. Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Country (2018-2023) Table 35. Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2018-2023) & ($ Millions) Table 36. Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Type (2018-2023) Table 37. Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2018-2023) & ($ Millions) Table 38. Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Application (2018-2023) Table 39. Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Region (2018-2023) & ($ Millions) Table 40. Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Region (2018-2023) Table 41. Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Type (2018-2023) & ($ Millions) Table 42. Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Type (2018-2023) Table 43. Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size by Application (2018-2023) & ($ Millions) Table 44. Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Application (2018-2023) Table 45. Key Market Drivers & Growth Opportunities of AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Table 46. Key Market Challenges & Risks of AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Table 47. Key Industry Trends of AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Table 48. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Forecast by Regions (2024-2029) & ($ Millions) Table 49. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share Forecast by Regions (2024-2029) Table 50. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Forecast by Type (2024-2029) & ($ Millions) Table 51. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Forecast by Application (2024-2029) & ($ Millions) Table 52. Infervision Details, Company Type, AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Area Served and Its Competitors Table 53. Infervision AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Product Offered Table 54. Infervision AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 55. Infervision Main Business Table 56. Infervision Latest Developments Table 57. BlueDot Details, Company Type, AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Area Served and Its Competitors Table 58. BlueDot AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Product Offered Table 59. BlueDot Main Business Table 60. BlueDot AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 61. BlueDot Latest Developments Table 62. Yitu Healthcare Details, Company Type, AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Area Served and Its Competitors Table 63. Yitu Healthcare AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Product Offered Table 64. Yitu Healthcare Main Business Table 65. Yitu Healthcare AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 66. Yitu Healthcare Latest Developments Table 67. SPHCC Details, Company Type, AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Area Served and Its Competitors Table 68. SPHCC AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Product Offered Table 69. SPHCC Main Business Table 70. SPHCC AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 71. SPHCC Latest Developments List of Figures Figure 1. AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth Rate 2018-2029 ($ Millions) Figure 6. AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Sales by Geographic Region (2018, 2022 & 2029) & ($ millions) Figure 7. AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Sales Market Share by Country/Region (2022) Figure 8. AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Sales Market Share by Country/Region (2018, 2022 & 2029) Figure 9. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Type in 2022 Figure 10. AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia in Hospital Figure 11. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market: Hospital (2018-2023) & ($ Millions) Figure 12. AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia in Center for Infectious Diseases Figure 13. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market: Center for Infectious Diseases (2018-2023) & ($ Millions) Figure 14. AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia in Other Figure 15. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market: Other (2018-2023) & ($ Millions) Figure 16. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Application in 2022 Figure 17. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Revenue Market Share by Player in 2022 Figure 18. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Regions (2018-2023) Figure 19. Americas AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size 2018-2023 ($ Millions) Figure 20. APAC AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size 2018-2023 ($ Millions) Figure 21. Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size 2018-2023 ($ Millions) Figure 22. Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size 2018-2023 ($ Millions) Figure 23. Americas AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Value Market Share by Country in 2022 Figure 24. United States AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth 2018-2023 ($ Millions) Figure 25. Canada AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth 2018-2023 ($ Millions) Figure 26. Mexico AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth 2018-2023 ($ Millions) Figure 27. Brazil AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth 2018-2023 ($ Millions) Figure 28. APAC AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Region in 2022 Figure 29. APAC AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Type in 2022 Figure 30. APAC AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Application in 2022 Figure 31. China AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth 2018-2023 ($ Millions) Figure 32. Japan AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth 2018-2023 ($ Millions) Figure 33. Korea AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth 2018-2023 ($ Millions) Figure 34. Southeast Asia AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth 2018-2023 ($ Millions) Figure 35. India AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth 2018-2023 ($ Millions) Figure 36. Australia AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth 2018-2023 ($ Millions) Figure 37. Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Country in 2022 Figure 38. Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Type (2018-2023) Figure 39. Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Application (2018-2023) Figure 40. Germany AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth 2018-2023 ($ Millions) Figure 41. France AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth 2018-2023 ($ Millions) Figure 42. UK AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth 2018-2023 ($ Millions) Figure 43. Italy AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth 2018-2023 ($ Millions) Figure 44. Russia AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth 2018-2023 ($ Millions) Figure 45. Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Region (2018-2023) Figure 46. Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Type (2018-2023) Figure 47. Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share by Application (2018-2023) Figure 48. Egypt AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth 2018-2023 ($ Millions) Figure 49. South Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth 2018-2023 ($ Millions) Figure 50. Israel AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth 2018-2023 ($ Millions) Figure 51. Turkey AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth 2018-2023 ($ Millions) Figure 52. GCC Country AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Growth 2018-2023 ($ Millions) Figure 53. Americas AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size 2024-2029 ($ Millions) Figure 54. APAC AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size 2024-2029 ($ Millions) Figure 55. Europe AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size 2024-2029 ($ Millions) Figure 56. Middle East & Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size 2024-2029 ($ Millions) Figure 57. United States AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size 2024-2029 ($ Millions) Figure 58. Canada AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size 2024-2029 ($ Millions) Figure 59. Mexico AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size 2024-2029 ($ Millions) Figure 60. Brazil AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size 2024-2029 ($ Millions) Figure 61. China AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size 2024-2029 ($ Millions) Figure 62. Japan AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size 2024-2029 ($ Millions) Figure 63. Korea AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size 2024-2029 ($ Millions) Figure 64. Southeast Asia AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size 2024-2029 ($ Millions) Figure 65. India AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size 2024-2029 ($ Millions) Figure 66. Australia AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size 2024-2029 ($ Millions) Figure 67. Germany AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size 2024-2029 ($ Millions) Figure 68. France AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size 2024-2029 ($ Millions) Figure 69. UK AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size 2024-2029 ($ Millions) Figure 70. Italy AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size 2024-2029 ($ Millions) Figure 71. Russia AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size 2024-2029 ($ Millions) Figure 72. Spain AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size 2024-2029 ($ Millions) Figure 73. Egypt AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size 2024-2029 ($ Millions) Figure 74. South Africa AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size 2024-2029 ($ Millions) Figure 75. Israel AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size 2024-2029 ($ Millions) Figure 76. Turkey AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size 2024-2029 ($ Millions) Figure 77. GCC Countries AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size 2024-2029 ($ Millions) Figure 78. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share Forecast by Type (2024-2029) Figure 79. Global AI in Novel Coronavirus PneumoniaAI in Novel Coronavirus PneumoniaAI in Novel Coronavirus Pneumonia Market Size Market Share Forecast by Application (2024-2029)
